Table 2.
DHF (n = 25) | SHF (n = 27) | p Value | |
Hypertension | 13 (52%) | 15 (53.8%) | 0.50 |
Coronary heart disease | 9 (36%) | 13 (48.1%) | 0.37 |
Previous MI | 6 (24%) | 10 (27%) | 0.37 |
Angina | 6 (24%) | 11 (40.7%) | 0.24 |
COPD | 6 (24%) | 6 (22%) | 0.87 |
Atrial fibrillation | 5 (20%) | 13 (48%) | 0.03 |
Spironolactone | 3 (12%) | 5 (18.5%) | 0.51 |
ACE inhibitors | 9 (36%) | 18 (66.7%) | 0.02 |
Digoxin | 4 (16%) | 8 (29.6%) | 0.32 |
β Blockers | 4 (16%) | 2 (7.4%) | 0.41 |
Statins | 5 (20%) | 8 (29%) | 0.42 |
Aspirin | 11 (44%) | 18 (66%) | 0.10 |
ACE, angiotensin converting enzyme; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction.